Research
Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study
BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3334 (Published 26 July 2017) Cite this as: BMJ 2017;358:j3334
Data supplement
Web Extra
- Data Supplement - Appendix: Supplementary materials
Related articles
- News Published: 03 April 2014; BMJ 348 doi:10.1136/bmj.g2579
- Research Published: 17 February 2016; BMJ 352 doi:10.1136/bmj.i637
- News Published: 07 February 2013; BMJ 346 doi:10.1136/bmj.f819
- Practice Published: 29 May 2008; BMJ 336 doi:10.1136/bmj.39527.628322.AD
- Head To Head Published: 09 July 2013; BMJ 347 doi:10.1136/bmj.f1880
- Letter Published: 24 October 2017; BMJ 359 doi:10.1136/bmj.j4866
- Research Published: 10 July 2019; BMJ 366 doi:10.1136/bmj.l4217
See more
- Vaping among US teens has doubled since 2017BMJ September 19, 2019, 366 l5653; DOI: https://doi.org/10.1136/bmj.l5653
- Burnout in healthcare: medical educators’ roleBMJ September 19, 2019, 366 l5570; DOI: https://doi.org/10.1136/bmj.l5570
- India bans e-cigarettes by executive orderBMJ September 19, 2019, 366 l5649; DOI: https://doi.org/10.1136/bmj.l5649
- Ophthalmologist who misled patients about treatment benefits is struck offBMJ September 19, 2019, 366 l5648; DOI: https://doi.org/10.1136/bmj.l5648
- Sixty seconds on . . . cancer bellsBMJ September 19, 2019, 366 l5644; DOI: https://doi.org/10.1136/bmj.l5644
Cited by...
- Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices
- Commitments by the Biopharmaceutical Industry to Clinical Trial Transparency: The Evolving Environment
- Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
- Reflections on the history of systematic reviews
- Sackler Colloquium on Improving the Reproducibility of Scientific Research: Standards for design and measurement would make clinical research reproducible and usable
- Availability and Use of Shared Data From Cardiometabolic Clinical Trials
- Characteristics and publication fate of unregistered and retrospectively registered clinical trials submitted to The BMJ over 4 years